REAFFIRMATION AND AMENDMENT AGREEMENTReaffirmation and Amendment Agreement • February 10th, 2023 • AgeX Therapeutics, Inc. • Pharmaceutical preparations
This REAFFIRMATION AND AMENDMENT AGREEMENT, dated as of February 9, 2023 (this “Agreement”) is made by AgeX Therapeutics, Inc., a Delaware corporation (the “Borrower”) in favor of Juvenescence Limited, a company incorporated in the Isle of Man with a company number of 018008V (the “Lender”).
